Follow-up of patients undergoing cancer treatment, especially for testicular and ovarian tumors and for hepatocellular carcinoma.
It is often used together with human chorionic gonadotropin.
This test is not recommended as a screening procedure for the detection of cancer in the general population.
This test is not designed to screen for neural tube defects.
This test is not useful for patients with pure seminoma or dysgerminoma.

How can we help you?